Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Journal of Managed Care Pharmacy : JMCP|December 4, 2009
Empirical methods to calculate an erythropoiesis-stimulating agent dose conversion ratio in nondialyzed patients with chronic kidney diseaseJeffrey Horowitz, Anil Agarwal, Fannie Huang, et al.Advances in Therapy|March 14, 2012
Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysisMachaon M K Bonafede, Shravanthi R Gandra, Crystal Watson, et al.Journal of Medical Economics|September 14, 2017
Differences in utility elicitation methods in cardiovascular disease: a systematic reviewMarissa Blieden Betts, Shravanthi R Gandra, Lung-I Cheng, et al.Current Medical Research and Opinion|March 16, 2013
Dosing patterns of three tumor necrosis factor blockers among patients with rheumatoid arthritis in a large United States managed care populationMaxine D Fisher, Crystal Watson, Kathleen M Fox, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 23, 2008
Further validation of an individualized migraine treatment satisfaction measureMona L Martin, Donald L Patrick, Donald M Bushnell, et al.Journal of Oncology|July 10, 2009
Estimation of Cachexia among Cancer Patients Based on Four DefinitionsKathleen M Fox, John M Brooks, Shravanthi R Gandra, et al.Clinical Therapeutics|January 31, 2012
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database studyMachaon M K Bonafede, Kathleen M Fox, Barbara H Johnson, et al.Advances in Therapy|March 8, 2014
Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sampleJason Yeaw, Crystal Watson, Kathleen M Fox, et al.Journal of Medical Economics|October 18, 2013
National and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plansAmie T Joyce, Shravanthi R Gandra, Kathleen M Fox, et al.Journal of Clinical Lipidology|December 7, 2016
Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapyJames P Burke, Ross J Simpson, Carly J Paoli, et al.Pageof 6